Evidence Synthesis
AAREYDRUGS reported a standard shift in its financial performance.
The company's .83% gross margin accelerated to, up from 1.07%.
Its .07% marginal operating leverage also accelerated, up from 0.87%.
On the revenue front, the company's revenue growth year-over-year (YoY) declined by .3%, a deceleration from -25%.
AAREYDRUGS' 199,690 shares traded on October 19, accelerating from 186,257 shares in the previous day.
The company's close price increased to .87 INR, up from 112.91 INR the previous day.